via examiner.com
The loopholes:
The legislation provides a 4-year, or until the drug is approved whichever comes first, exemption for doctors involved in clinical trials and product development studies. This means if a doctor is being paid by a pharmaceutical company to study a medication not yet approved, you will have to wait four years, or until post approval, to discover the funding source.
The legislation does not cover health advocacy groups who frequently have a substantial influence over how certain medical conditions are treated and frequently receive large donations from pharmaceutical companies and medical device companies.
No comments:
Post a Comment